Company Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 17/04/2026 pm IST			5-day change	1st Jan Change
329.30 ^DKK	+4.54%		+14.42%	-29.40%

14/04	Zealand Pharma A/S Announces the Appointment of Eric Rojas as Head of Investor Relations, Effective April 15, 2026	CI
26/03	Zealand Pharma A/S Approves Management Changes	CI

Business description: Zealand Pharma A/S

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity.

At the end of 2025, the Group had a portfolio of 8 products in clinical development (including 3 in phase III, 3 in phase II and 2 in phase I), and 1 product in preclinical development.

Number of employees: 491

Sales by Activity: Zealand Pharma A/S

Fiscal Period: December	2021 (DKK)	2022 (DKK)	2023 (DKK)	2024 (DKK)	2025 (DKK)
Biotechnology	29Cr	10Cr	34Cr	6.27Cr	921.49Cr

See all business segments

Geographical breakdown of sales: Zealand Pharma A/S

Fiscal Period: December	2021 (DKK)	2022 (DKK)	2023 (DKK)	2024 (DKK)	2025 (DKK)
Switzerland	-	-	-	-	918Cr
Denmark	-	3.5Cr	4.42Cr	6.23Cr	3.49Cr
United States	24Cr	6.9Cr	40.94L	4L	-
Germany	5.3Cr	-	29Cr	-	-

See all geographic segments

Executive Committee: Zealand Pharma A/S

Manager	Title	Age	Since
Adam Sinding Steensberg CEO	Chief Executive Officer	52	30/03/2022
Henriette Wennicke DFI	Director of Finance/CFO	-	01/11/2022
David Kendall CTO	Chief Tech/Sci/R&D Officer	64	02/06/2022
Ivan Møller COO	Chief Operating Officer	54	01/03/2018
Frederik Barfoed Beck PRN	Corporate Officer/Principal	59	-

See ZEALAND PHARMA A/S governance

Composition of the Board of Directors: Zealand Pharma A/S

Director	Title	Age	Since
Alf Gunnar Martin Nicklasson CHM	Chairman	71	-
Kirsten Drejer BRD	Director/Board Member	69	19/04/2018
Leonard Kruimer BRD	Director/Board Member	68	04/04/2019
Frederik Barfoed Beck BRD	Director/Board Member	59	01/01/2020
Anneline Nansen BRD	Director/Board Member	57	01/09/2021
Enrique Conterno BRD	Director/Board Member	59	20/03/2024
Elaine Sullivan BRD	Director/Board Member	65	20/03/2024
Ludovic Otterbein BRD	Director/Board Member	53	20/03/2024
Adam Nygaard BRD	Director/Board Member	-	20/03/2024

Composition of the Board of Directors

Shareholders: Zealand Pharma A/S

Name	Equities	%	Valuation
Van Herk Investments BV 9.999 %	71,51,504	9.999 %	325 M kr
ZEALAND PHARMA A/S 1.269 %	9,07,905	1.269 %	41 M kr
Nykredit Bank A/S (Investment Management) 0.7942 %	5,68,072	0.7942 %	26 M kr
Carnegie Investment Bank AB (Investment Management Denmark) 0.2416 %	1,72,776	0.2416 %	8 M kr
Mackenzie Investments Europe Ltd. 0.2191 %	1,56,702	0.2191 %	7 M kr

List of ZEALAND PHARMA A/S shareholders

Holdings: Zealand Pharma A/S

Name	Equities	%	Valuation
ZEALAND PHARMA A/S 1.27%	9,07,905	1.27%	41 M $

Company details: Zealand Pharma A/S

Zealand Pharma A/S

Sydmarken 11

2860, Soborg

+45 88 77 36 00

http://www.zealandpharma.com

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ZEALAND PHARMA A/S	+4.54%	+14.42%	-22.43%	+47.67%	367.3Cr
ARGENX SE	+1.01%	+5.25%	+36.93%	+108.24%	5.27TCr
WUXI APPTEC CO., LTD.	-5.93%	-6.53%	+88.06%	+25.24%	4.41TCr
INSMED INCORPORATED	+1.18%	-6.67%	+98.87%	+707.15%	3.12TCr
BIONTECH SE	+0.78%	+7.77%	+4.21%	-15.49%	2.6TCr
SUMMIT THERAPEUTICS INC.	+2.99%	+27.86%	+2.19%	+1,452.47%	1.95TCr
WUXI BIOLOGICS (CAYMAN) INC.	-0.34%	+1.02%	+65.38%	-31.66%	1.89TCr
AKESO, INC.	-2.32%	+7.11%	+66.97%	+240.88%	1.78TCr
GENMAB A/S	+0.78%	+0.78%	+39.68%	-34.90%	1.75TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.50%	+4.27%	+69.33%	-	1.55TCr
Average	+0.06%	+5.77%	+44.92%	+277.73%	2.47TCr
Weighted average by Cap.	-0.58%	+3.47%	+53.38%	+259.57%